Skip to content
WeighLab

Coivas vs Ivy Rx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Coivas

Provider comparison

Shoppers who want low published compounded prices with no membership fee and a cancel-any-time subscription.

Semaglutide / month
$119/moStarting price during a fall sale, compounded
Tirzepatide / month
$199/moStarting price, compounded
Index 77/100 · Grade CChecked October 2026

Ivy Rx

Provider comparison

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Semaglutide / month
$77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
Tirzepatide / month
Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
Index 76/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Coivas has the higher Cost-Efficiency Index: 77/100 versus 76/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Coivas
All 50 states
Ivy Rx
Not published; confirm eligibility

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Coivas

Ivy Rx

Semaglutide / month
Coivas: $119/moStarting price during a fall sale, compounded
Ivy Rx: $77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
Tirzepatide / month
Coivas: $199/moStarting price, compounded
Ivy Rx: Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
Semaglutide / year (modeled)
Coivas: $1,428
Ivy Rx: $924
Tirzepatide / year (modeled)
Coivas: $2,388
Ivy Rx: —
State availability
Coivas: All 50 states
Ivy Rx: Not published; confirm eligibility
Oral / sublingual option listed
Coivas: Not listed
Ivy Rx: Not listed
Brand-name access listed
Coivas: Not confirmed
Ivy Rx: Yes
Provider facts checked
Coivas: October 2026
Ivy Rx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Coivas

Shoppers who want low published compounded prices with no membership fee and a cancel-any-time subscription.

Reasons to consider it

  • Publishes its prices: semaglutide from $119 and tirzepatide from $199 a month, with no membership fee
  • Names its clinical provider group, Beluga Health
  • Says it serves all 50 states, and shows a LegitScript seal

What to weigh up

  • The semaglutide price is a "from" figure shown under a fall-sale banner, so confirm what month two costs at your dose before paying
  • No single named compounding pharmacy; it varies by location and medication
  • The money-back guarantee needs six straight months of paid enrollment and no weight loss at all

Ivy Rx

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Reasons to consider it

  • Publishes a $77 standard injection headline and separate $69 microdose option
  • Says the injection price stays the same at every dose
  • Includes same-day physician review and free delivery

What to weigh up

  • The shared starting headline does not establish a separate public tirzepatide price
  • No full state list or individual dispensing pharmacy is published
  • Terms describe one- or three-month initial plans followed by monthly automatic renewal

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

CoivasIvy Rx
Normalized Cost/Month
Coivas:
76/100
Ivy Rx:
97/100
Price Transparency
Coivas:
78/100
Ivy Rx:
94/100
Nationwide Access
Coivas:
86/100
Ivy Rx:
24/100
Formulation Options
Coivas:
66/100
Ivy Rx:
66/100
Clinical Oversight
Coivas:
85/100
Ivy Rx:
82/100
Contract Flexibility
Coivas:
71/100
Ivy Rx:
85/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.